NCT02855359 Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma Status TERMINATED Phase PHASE2
NCT02849990 A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy Status COMPLETED Phase PHASE2
NCT02844582 Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Status TERMINATED Phase PHASE2
NCT02815059 Study of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and Prednisone Status WITHDRAWN Phase PHASE1
NCT02809573 Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients Status COMPLETED Phase PHASE1
NCT02809079 Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients Status UNKNOWN Phase PHASE4
NCT02807805 Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02806947 A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501) Status COMPLETED Phase PHASE2
NCT02797717 Treatment for Classical Hodgkin Lymphoma in Children and Adolescents Status RECRUITING Phase NA
NCT02789878 Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer Status COMPLETED Phase PHASE2
NCT02784210 Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques Status RECRUITING Phase PHASE2
NCT02776605 Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia Status UNKNOWN Phase PHASE2
NCT02773550 Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma Status TERMINATED Phase PHASE4
NCT02767674 Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma Status UNKNOWN Phase PHASE3
NCT02767089 The Dose Response of Prednisone on Biochemical and Clinical Makers in Adult Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02758132 Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases Status TERMINATED Phase PHASE2
NCT02753764 Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma Status COMPLETED Phase PHASE2